These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prevention and remission of diabetic nephropathy]. Sugimoto T; Nakamura Y; Makino H Nihon Rinsho; 2003 Jul; 61(7):1167-71. PubMed ID: 12877079 [TBL] [Abstract][Full Text] [Related]
4. [Role of oxidative stress in pathogenesis of diabetic nephropathy]. Inoguchi T Nihon Jinzo Gakkai Shi; 2011; 53(7):1016-20. PubMed ID: 22073866 [No Abstract] [Full Text] [Related]
5. [Management of micro-inflammation in uremia]. Massy ZA; Choukroun G Nephrologie; 2003; 24(7):415-7. PubMed ID: 14650756 [TBL] [Abstract][Full Text] [Related]
6. [Management of diabetic nephropathy with nephrotic syndrome]. Eguchi J; Wada J; Makino H Nihon Rinsho; 2002 Oct; 60 Suppl 10():430-6. PubMed ID: 12430265 [No Abstract] [Full Text] [Related]
7. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975 [TBL] [Abstract][Full Text] [Related]
11. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy]. Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786 [TBL] [Abstract][Full Text] [Related]
12. Effects of ACE inhibition on the course of nephropathy in type I diabetes mellitus. Meinders AE; Hes R; de Leeuw PW Neth J Med; 1992 Jun; 40(5-6):217-20. PubMed ID: 1436257 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy. Agarwal R Am J Physiol Renal Physiol; 2006 Mar; 290(3):F600-5. PubMed ID: 16159895 [TBL] [Abstract][Full Text] [Related]
14. Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy. How HY; Sibai BM J Matern Fetal Neonatal Med; 2002 Dec; 12(6):402-7. PubMed ID: 12683651 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blockade in diabetic nephropathy. Andersen S Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059 [No Abstract] [Full Text] [Related]
16. [Erythropoietin-depletion induced anemia in early or advanced diabetic nephropathy]. Inomata S Nihon Rinsho; 2002 Aug; 60 Suppl 8():504-9. PubMed ID: 12355798 [No Abstract] [Full Text] [Related]
17. [New findings with RAS inhibitors in diabetic nephropathy]. Ito S Nihon Jinzo Gakkai Shi; 2007; 49(5):485-90. PubMed ID: 17695809 [No Abstract] [Full Text] [Related]
18. [Nephropathy in type-1 diabetes]. Sawicki PT; Berger M Dtsch Med Wochenschr; 1993 Mar; 118(9):319-21. PubMed ID: 8444117 [No Abstract] [Full Text] [Related]
19. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists]. Tesar V Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169 [TBL] [Abstract][Full Text] [Related]